Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification

Alessandro Pini, Andrea Giuliani, Chiara Falciani, Ylenia Runci, Claudia Ricci, Barbara Lelli, Monica Malossi, Paolo Neri, Gian Maria Rossolini, Luisa Bracci

Research output: Contribution to journalArticle

100 Citations (Scopus)

Abstract

A large 10-mer phage peptide library was panned against whole Escherichia coli cells, and an antimicrobial peptide (QEKIRVRLSA) was selected. The peptide was synthesized in monomeric and dendrimeric tetrabranched form (multiple antigen peptide [MAP]), which generally allows a dramatic increase of peptide stability to peptidases and proteases. The antibacterial activity of the dendrimeric peptide against E. coli was much higher than that of the monomeric form. Modification of the original sequence, by residue substitution or sequence shortening, produced three different MAPs, M4 (QAKIRVRLSA), M5 (KIRVRLSA), and M6 (QKKIRVRLSA) with enhanced stability to natural degradation and antimicrobial activity against a large panel of gram-negative bacteria. The MICs of the most potent peptide, M6, were as low as 4 to 8 μg/ml against recent clinical isolates of multidrug-resistant Pseudomonas aeruginosa and members of the Enterobacteriaceae. The same dendrimeric peptides showed high stability to blood proteases, low hemolytic activity, and low cytotoxic effects on eukaryotic cells, making them promising candidates for the development of new antibacterial drugs.

Original languageEnglish
Pages (from-to)2665-2672
Number of pages8
JournalAntimicrobial Agents and Chemotherapy
Volume49
Issue number7
DOIs
Publication statusPublished - Jul 2005

Fingerprint

Bacteriophages
Peptides
Peptide Hydrolases
Escherichia coli
Peptide Library
Eukaryotic Cells
Enterobacteriaceae
Gram-Negative Bacteria
Pseudomonas aeruginosa
Antigens
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification. / Pini, Alessandro; Giuliani, Andrea; Falciani, Chiara; Runci, Ylenia; Ricci, Claudia; Lelli, Barbara; Malossi, Monica; Neri, Paolo; Rossolini, Gian Maria; Bracci, Luisa.

In: Antimicrobial Agents and Chemotherapy, Vol. 49, No. 7, 07.2005, p. 2665-2672.

Research output: Contribution to journalArticle

Pini, A, Giuliani, A, Falciani, C, Runci, Y, Ricci, C, Lelli, B, Malossi, M, Neri, P, Rossolini, GM & Bracci, L 2005, 'Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification', Antimicrobial Agents and Chemotherapy, vol. 49, no. 7, pp. 2665-2672. https://doi.org/10.1128/AAC.49.7.2665-2672.2005
Pini, Alessandro ; Giuliani, Andrea ; Falciani, Chiara ; Runci, Ylenia ; Ricci, Claudia ; Lelli, Barbara ; Malossi, Monica ; Neri, Paolo ; Rossolini, Gian Maria ; Bracci, Luisa. / Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification. In: Antimicrobial Agents and Chemotherapy. 2005 ; Vol. 49, No. 7. pp. 2665-2672.
@article{51fb28a05edd4107905ea80668ad5bed,
title = "Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification",
abstract = "A large 10-mer phage peptide library was panned against whole Escherichia coli cells, and an antimicrobial peptide (QEKIRVRLSA) was selected. The peptide was synthesized in monomeric and dendrimeric tetrabranched form (multiple antigen peptide [MAP]), which generally allows a dramatic increase of peptide stability to peptidases and proteases. The antibacterial activity of the dendrimeric peptide against E. coli was much higher than that of the monomeric form. Modification of the original sequence, by residue substitution or sequence shortening, produced three different MAPs, M4 (QAKIRVRLSA), M5 (KIRVRLSA), and M6 (QKKIRVRLSA) with enhanced stability to natural degradation and antimicrobial activity against a large panel of gram-negative bacteria. The MICs of the most potent peptide, M6, were as low as 4 to 8 μg/ml against recent clinical isolates of multidrug-resistant Pseudomonas aeruginosa and members of the Enterobacteriaceae. The same dendrimeric peptides showed high stability to blood proteases, low hemolytic activity, and low cytotoxic effects on eukaryotic cells, making them promising candidates for the development of new antibacterial drugs.",
author = "Alessandro Pini and Andrea Giuliani and Chiara Falciani and Ylenia Runci and Claudia Ricci and Barbara Lelli and Monica Malossi and Paolo Neri and Rossolini, {Gian Maria} and Luisa Bracci",
year = "2005",
month = "7",
doi = "10.1128/AAC.49.7.2665-2672.2005",
language = "English",
volume = "49",
pages = "2665--2672",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "7",

}

TY - JOUR

T1 - Antimicrobial activity of novel dendrimeric peptides obtained by phage display selection and rational modification

AU - Pini, Alessandro

AU - Giuliani, Andrea

AU - Falciani, Chiara

AU - Runci, Ylenia

AU - Ricci, Claudia

AU - Lelli, Barbara

AU - Malossi, Monica

AU - Neri, Paolo

AU - Rossolini, Gian Maria

AU - Bracci, Luisa

PY - 2005/7

Y1 - 2005/7

N2 - A large 10-mer phage peptide library was panned against whole Escherichia coli cells, and an antimicrobial peptide (QEKIRVRLSA) was selected. The peptide was synthesized in monomeric and dendrimeric tetrabranched form (multiple antigen peptide [MAP]), which generally allows a dramatic increase of peptide stability to peptidases and proteases. The antibacterial activity of the dendrimeric peptide against E. coli was much higher than that of the monomeric form. Modification of the original sequence, by residue substitution or sequence shortening, produced three different MAPs, M4 (QAKIRVRLSA), M5 (KIRVRLSA), and M6 (QKKIRVRLSA) with enhanced stability to natural degradation and antimicrobial activity against a large panel of gram-negative bacteria. The MICs of the most potent peptide, M6, were as low as 4 to 8 μg/ml against recent clinical isolates of multidrug-resistant Pseudomonas aeruginosa and members of the Enterobacteriaceae. The same dendrimeric peptides showed high stability to blood proteases, low hemolytic activity, and low cytotoxic effects on eukaryotic cells, making them promising candidates for the development of new antibacterial drugs.

AB - A large 10-mer phage peptide library was panned against whole Escherichia coli cells, and an antimicrobial peptide (QEKIRVRLSA) was selected. The peptide was synthesized in monomeric and dendrimeric tetrabranched form (multiple antigen peptide [MAP]), which generally allows a dramatic increase of peptide stability to peptidases and proteases. The antibacterial activity of the dendrimeric peptide against E. coli was much higher than that of the monomeric form. Modification of the original sequence, by residue substitution or sequence shortening, produced three different MAPs, M4 (QAKIRVRLSA), M5 (KIRVRLSA), and M6 (QKKIRVRLSA) with enhanced stability to natural degradation and antimicrobial activity against a large panel of gram-negative bacteria. The MICs of the most potent peptide, M6, were as low as 4 to 8 μg/ml against recent clinical isolates of multidrug-resistant Pseudomonas aeruginosa and members of the Enterobacteriaceae. The same dendrimeric peptides showed high stability to blood proteases, low hemolytic activity, and low cytotoxic effects on eukaryotic cells, making them promising candidates for the development of new antibacterial drugs.

UR - http://www.scopus.com/inward/record.url?scp=21444448725&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=21444448725&partnerID=8YFLogxK

U2 - 10.1128/AAC.49.7.2665-2672.2005

DO - 10.1128/AAC.49.7.2665-2672.2005

M3 - Article

C2 - 15980334

AN - SCOPUS:21444448725

VL - 49

SP - 2665

EP - 2672

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 7

ER -